A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas
Conditions: Head and Neck Carcinoma; Adenocarcinoma; Recurrent Disease; Distantly Metastatic Malignant Neoplasm Intervention: Drug: Anlotinib Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials